Literature DB >> 10488442

A molecular basis for opiate action.

D Massotte1, B L Kieffer.   

Abstract

Opioid receptors mediate the strong analgesic and addictive actions of exogenous opiates, the prototype of which is morphine. The opioid system consists of a family of endogenous opioid peptides and three receptor types, m, d and k. It is widely distributed throughout the CNS and regulates a large diversity of physiological functions, including pain perception and mood control. The recent cloning of opioid receptors has opened up a new era in opioid research. The molecular basis of opioid action may now be addressed by in vitro structure-function studies of recombinant receptors and by in vivo gene targeting. Novel drug design strategies based on data obtained from molecular approaches will be developed in order to generate the long-sought non-addictive analgesic.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10488442     DOI: 10.1042/bse0330065

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  5 in total

1.  Differentiation of delta, mu, and kappa opioid receptor agonists based on pharmacophore development and computed physicochemical properties.

Authors:  M Filizola; H O Villar; G H Loew
Journal:  J Comput Aided Mol Des       Date:  2001-04       Impact factor: 3.686

2.  Endomorphin-1: induction of motor behavior and lack of receptor desensitization.

Authors:  A Mehta; G Bot; T Reisine; M F Chesselet
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

Review 3.  Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.

Authors:  János Marton; Anikó Fekete; Paul Cumming; Sándor Hosztafi; Pál Mikecz; Gjermund Henriksen
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

Review 4.  Biased agonism: An emerging paradigm in GPCR drug discovery.

Authors:  Zoran Rankovic; Tarsis F Brust; Laura M Bohn
Journal:  Bioorg Med Chem Lett       Date:  2015-12-09       Impact factor: 2.823

5.  Enhanced spontaneous activity of the mu opioid receptor by cysteine mutations: characterization of a tool for inverse agonist screening.

Authors:  Karl Brillet; Brigitte L Kieffer; Dominique Massotte
Journal:  BMC Pharmacol       Date:  2003-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.